Prostate artery embolization for enlarged prostate
Part of Kidney & urinary clinical trials.
This trial tests a new way to block blood flow to the prostate to shrink it and improve urinary symptoms. It uses a special gel called SquidPERI during a standard procedure called prostate artery embolization (PAE).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled to have a prostate artery embolization (PAE) as part of your regular care.
- You have signed a consent form after being informed about the study.
- You are covered by French social security and understand French well.
- You have not had a PAE before and are not allergic to iodine or have severe liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a procedure called prostate artery embolization (PAE) before radiation therapy for prostate cancer. The goal is to shrink the prostate and reduce urinary symptoms, which may improve the effectiveness of radiation and your quality of life.
This trial compares artery embolization (blocking blood flow to the prostate) with standard surgery for urinary symptoms caused by an enlarged prostate. It may help patients who have moderate-to-severe bladder outlet symptoms and are looking for a treatment option when medicine didn’t work (or they don’t want medicine).
This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.
This trial compares two minimally invasive treatments—using a special glue versus tiny beads—to block arteries and shrink an enlarged prostate. It aims to improve urine flow and reduce symptoms without surgery.
This trial compares two catheter-based treatments—TUMT and PAE—to see which better reduces severe urinary symptoms caused by an enlarged prostate (BPH). It may help you choose a treatment option if medicines are not suitable or you still have significant symptoms.
This trial tests a new device that uses pulsed electric fields to shrink an enlarged prostate (benign prostatic hyperplasia, or BPH). It's for men who have tried medication but still have bothersome symptoms.
Hear when a new Benign Prostate Hypertrophy(BPH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.